Alpha-synuclein based biomarkers have dominated the Parksinon’s disease field over the past few years. Dr. Andrew Siderowf shares his views on the future of these biomarkers and what else the field may have in store.
Read MoreDr. Aasef Shaikh shares the exciting developments in the world of tremor and how he believes the use of technology will help answer some of the field’s big questions, including the personalization of treatment.
Read MoreDr. Alexander Lehn breaks down functional movement disorders; what is happening in the brain, what are the potential risk factors and what future treatments and clinical trials we have to look forward to.
Read MoreDr. Kishore Kumar shares the new genes associated with Parkinson’s disease, dystonia, and ataxia. He also shares how new technologies, like long read sequencing, can assist in finding epigenetic changes.
Read MoreProf. Jeffrey Kordower shares the data in support of #PD being a copathology disease and what strategies may be in the future for protein aggregate clearance in age-related neurodegenerative diseases.
Read MoreProf. Brit Mollenhauer shares her excitement about basic science, including biomarker research, and how she believes MDS’s diversity can help foster more collaboration between clinicians and basic scientists.
Read MoreThe last full day of #mdscongress 2024 was packed full of sessions and other activities. Prof. Huw Morris dives into the learnings from the day and recollects the excitement surrounding the much-loved Video Challenge.
Read MoreAward Replay: Dr. Eduardo Fernandez interviews Professor Günther Deuschl and Dr. Robin Wolke on their article on the challenges levodopa poses when predicting the outcome of subthalamic deep brain stimulation — which was recently named the Movement Disorders Clinical Practice journal Research Article of the Year. Read the article
Read MoreDr. Sara Schaefer interviews Dr. Jennifer Goldman about her systematic review and meta-analysis on subjective cognitive complaints in Parkinson’s disease, including the prevalence, epidemiology, and correlation with objective cognitive findings and neuropsychiatric disease. The article was recently named the Movement Disorders journal Review Article of the Year.
Read MoreDr. Edwin Jabbari, a 2024 MDS Junior Award Winner, joins the MDS Podcast to share the results of his award-winning work on the development of a 4-repeat tau SAA and what led him to this work. He also shares helpful tips for other junior researchers.
Read More